Eradication Rate of Helicobacter pylori using a Two-week Quadruple Therapy: A Report from Southern Iran.

BACKGROUND The use of quadruple therapy for Helicobacter pylori (H. pylori) eradication is a highly efficacious, gold standard regimen. However, according to a number of studies, this regimen has numerous compliance problems and adverse effects. In the current study we have evaluated the H. pylori e...

Descripción completa

Detalles Bibliográficos
Publicado en:Middle East Journal of Digestive Diseases Vol. 5; no. 2; pp. 81 - 86
Autores principales: Masoodi, Mohsen, Panahian, Mohammad, Rezadoost, Amirmansoor, Heidari, Amin
Formato: clinical trial research tables/charts Journal Article
Publicado: Iranian Association of Gastroenterology & Hepatology Apr2013
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=89080036&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 89080036
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20085230
        BG4K
      jtl: Middle East Journal of Digestive Diseases
      issn: 20085230
      maglogo: N
    pubinfo:
      dt: Apr2013
      vid: 5
      iid: 2
      pid: 70725
      pub: Iranian Association of Gastroenterology & Hepatology
    artinfo:
      ui:
        89080036
        89080036
        107957498
        89080036
      ppf: 81
      ppct: 5
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Eradication Rate of Helicobacter pylori using a Two-week Quadruple Therapy: A Report from Southern Iran.
      aug:
        au:
          Masoodi, Mohsen
          Panahian, Mohammad
          Rezadoost, Amirmansoor
          Heidari, Amin
        affil: Department of Internal Medicine, Gastrointestinal and Liver Disease Research Center (GILDRC), Digestive Disease Research Institute (DDRI), Colorectal Research Center, Rasool Akram Hospital, Tehran University of Medical Sciences, Tehran, Iran
      sug:
        subj:
          Helicobacter Infections Therapy
          Drug Combinations Administration and Dosage
          Disease Eradication Methods
          Human
          Iran
          Geographic Locations
          Time Factors
          Helicobacter Pylori
          Public Health
          Treatment Outcomes Evaluation
          Clinical Trials
      ab: BACKGROUND The use of quadruple therapy for Helicobacter pylori (H. pylori) eradication is a highly efficacious, gold standard regimen. However, according to a number of studies, this regimen has numerous compliance problems and adverse effects. In the current study we have evaluated the H. pylori eradication rate following a quadruple therapy that included omeprazole, bismuth subcitrate, amoxicillin, and metronidazole in Hormozgan, the most southern province in Iran. Hormozgan Province has high rates of H, pylori infection and its related disorders. METHODS A total of 100 patients diagnosed with dyspepsia and H. pylori infection as documented by the (13)C-urea breath test (UBT) or rapid urease test (RUT) were treated with the following quadruple regimen: bismuth subcitrate (120 mg, 2 tablets/ql2h), amoxicillin (500 mg/q8h), metronidazole (250 mg/q8h) and omeprazole (20 mg/ql2h) for a two-week period. Our primary efficacy outcome was H. pylori eradication as established by a negative UBT at least four weeks after the end of treatment. RESULTS Eradication rates were 79%.and 82.3%, respectively, based on the intention-to-treat and per-protocol analyses. Quadruple therapy had a similar effect in women (81%) and men (83.3%) for the eradication of H, pylori, which was not statistically significant. H. pylori eradication rates according to age groups were: 16-20 years (100%), 21-40 years (81%), and 41-60 years (77.8%; p=0.001). There was no significant difference in H. pylori eradication rate between genders in those less than 20 years of age and the middle age group. However in the older group the eradication rate was significantly higher in women (100%) compared to men (66.6%). CONCLUSION A two-week quadruple therapy that includes omeprazole, bismuth subcitrate, amoxicillin and metronidazole is a highly effective treatment for H, pylori infection. This treatment has an acceptable eradication rate in Southern Iran. The eradication rate appears to be lower in older men compared with younger men or in women.
      pubtype: Academic Journal
      doctype:
        clinical trial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N